Treatment outcomes and predicting factors for diabetic macular edema treated with ranibizumab - One-year real-life results in Taiwan.

Lai, Tso-Ting; Yang, Chung-May; Yang, Chang-Hao; Ho, Tzyy-Chang; Hsieh, Yi-Ting

Lai, Tso-Ting; Yang, Chung-May; Yang, Chang-Hao; Ho, Tzyy-Chang; Hsieh, Yi-Ting.

Lai TT; Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Yang CM; Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Yang CH; Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Ho TC; Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Hsieh YT; Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: ythyth@gmail.com.

J Formos Med Assoc ; 118(1 Pt 1): 194-202, 2019 Jan.

Article en En | MEDLINE | ID: mdl-29609918

Asunto(s)

Inhibidores de la Angiogénesis/uso terapéutico; Retinopatía Diabética/complicaciones; Edema Macular/tratamiento farmacológico; Ranibizumab/uso terapéutico; Anciano; Femenino; Humanos; Edema Macular/diagnóstico por imagen; Edema Macular/etiología; Masculino; Persona de Mediana Edad; Análisis de Regresión; Estudios Retrospectivos; Taiwán; Tomografía de Coherencia Óptica; Resultado del Tratamiento; Agudeza Visual

Palabras clave

Diabetic retinopathy; Macular edema; Optical coherence tomography; Ranibizumab; Triamcinolone acetonide

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Edema Macular / Inhibidores de la Angiogénesis / Retinopatía Diabética / Ranibizumab Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google